Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aramark (NYSE: ARMK) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Aramark is a Delaware-incorporated food service and facilities management company headquartered in Philadelphia, Pennsylvania, with common stock registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ARMK.
Through this page, readers can review Aramark’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically contain information about revenue, operating income, segment performance, cash flow, leverage ratio, and risk factors. These filings also describe the company’s North American and international food and support services operations, major lines of business, and key accounting and reporting policies.
Aramark’s current reports on Form 8-K document material events such as earnings releases, results of operations, and changes to its credit agreements. Recent 8-K filings have detailed amendments to the company’s credit agreement, including the repricing and refinancing of U.S. Term B loans with maturities extending into 2028 and 2030, and furnished press releases announcing quarterly and annual financial results.
The company’s definitive proxy statement on Schedule 14A provides insight into governance and executive compensation, including proposals submitted to shareholders, performance metrics used in incentive plans, and information about the annual meeting. This document discusses topics such as revenue and profitability growth, net new business, leverage ratio, and cash flow, and includes reconciliations of non-GAAP measures to GAAP where applicable.
Stock Titan enhances these filings with AI-powered summaries designed to explain complex sections in simpler terms. Users can quickly identify key points from lengthy documents, such as trends in Aramark’s revenue and operating income, changes in leverage and capital structure, and the rationale behind amendments to its credit facilities. The filings page also surfaces Form 4 insider transaction reports when available, allowing investors to track share transactions by directors and officers alongside the company’s broader financial and strategic disclosures.
Aramark (ARMK) reported an insider transaction by its SVP and CFO. On 11/10/2025 (Transaction Code F), 3,809 shares of common stock were tied to a previously granted performance stock unit award after the company determined the financial performance criteria had been satisfied.
The earned shares include accrued dividend equivalents and remain subject to a time-based vesting restriction, scheduled to vest on October 2, 2026, per the award terms. Following the reported activity, the officer beneficially owned 53,975.367 shares; the balance reflects an adjustment to a previously understated number of shares.
Aramark (ARMK): CEO Form 4 filing — On 11/10/2025, the Chief Executive Officer and Director reported acquiring 150,742 shares of common stock at $0 tied to a previously granted performance stock unit award. The award was earned after financial performance criteria were determined to be satisfied for the three-year period ending October 3, 2025, and includes dividend equivalents accrued since grant.
These shares remain subject to a time-based vesting restriction and will vest on October 2, 2026, per the award terms. Following the reported transaction and an adjustment to correct a previously understated balance, beneficial ownership stands at 983,290.779 shares, held directly.
Aramark (ARMK) reported an insider equity change by its SVP, Controller and CAO. On 11/10/2025, the officer acquired 3,809 shares of common stock at a reported price of $0, based on a previously granted performance stock unit award after the company’s financial performance criteria were determined to be satisfied for the three-year period ending October 3, 2025.
The reported shares include dividend equivalents accrued since grant and remain subject to a time‑based vesting restriction; they will vest on October 2, 2026, subject to the award’s terms. Following the transaction, the officer’s beneficial ownership is 37,262.895 shares, held directly. The filing notes the balance reflects an adjustment to a previously understated number of shares.
Aramark (ARMK) reported an insider equity transaction by its SVP and General Counsel. On 11/10/2025, performance criteria were certified for a previously granted performance stock unit award, resulting in an acquisition of 23,803 shares of common stock at $0.
The award reflects shares earned for the three-year period ending October 3, 2025, and includes dividend equivalents accrued since grant. These shares remain subject to a time-based vesting restriction and will vest on October 2, 2026, per award terms. Following the reported transaction, the reporting person beneficially owns 120,734.448 shares directly.
The filing also notes the balance reflects an adjustment to a previously understated number of shares.
Aramark officer (COO, U.S. Food & Facilities) reported acquiring 29,356 shares of common stock at $0 on 11/10/2025. The shares were earned from a previously granted performance stock unit award after financial criteria were determined to be satisfied and include dividend equivalents accrued since grant.
These shares remain subject to time-based vesting and will vest on October 2, 2026, per award terms. Following the transaction, beneficial ownership stands at 288,519.536 shares (direct). The filing notes the balance reflects an adjustment to a previously understated share count.
Aramark (ARMK) disclosed that its SVP & Chief HR Officer reported acquiring 19,769 shares of common stock at $0 on 11/10/2025, earned from a previously granted performance stock unit (PSU) award. The shares were determined based on financial performance criteria for the three-year period ending October 3, 2025 and include dividend equivalents accrued since grant.
These shares remain subject to a time-based vesting restriction and will vest on October 2, 2026, subject to the award’s terms. Following the transaction, the officer’s beneficial ownership stands at 73,837.879 shares, held directly. A footnote indicates the balance reflects an adjustment to a previously understated share count.
Aramark (ARMK) reported an insider transaction on 10/10/2025. A director acquired 699 fully vested deferred stock units at $0 by electing to defer the cash retainer into stock units. These units will be settled in shares of common stock on the first day of the seventh month after the director leaves the board.
Following the transaction, the director’s beneficial ownership is 7,966.29 shares, held directly. The balance reflects an adjustment to a previously understated number of shares.
Aramark (ARMK) reported a Form 4 for a director showing the acquisition of 858 fully vested deferred stock units on 10/10/2025 at $0, reflecting the director’s election to defer the cash retainer into units.
The units will be settled in common stock on the first day of the seventh month after the director leaves the board. Following the transaction, beneficial ownership was 60,192.32 shares direct and 12,475 shares indirect by a trust. The balance reflects an adjustment to a previously understated share count.
Aramark insider activity: James J. Tarangelo, Aramark (ARMK) SVP and CFO, reported option-related transactions dated 09/18/2025. He exercised 7,909 stock options with a $23.55 exercise price and simultaneously sold 6,199 shares to cover the exercise price and tax withholding, resulting in 50,164.846 shares beneficially owned after the transactions. The exercised options were fully vested and expire on 11/20/2025. The filing is signed by an attorney-in-fact on 09/19/2025.
Aramark (ARMK) Form 4: James J. Tarangelo, SVP and Chief Financial Officer, reported an acquisition on 08/20/2025 of 60.475 common stock units described as dividend equivalent rights tied to restricted stock units; the units were recorded at a $0 price because they represent accrued dividend equivalents rather than a cash purchase. After this transaction Tarangelo beneficially owns 48,454.846 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The filing notes the dividend equivalents vest on the same schedule as the underlying restricted stock awards.